These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 16965694

  • 1. [New advances in clinical trials of cancer vaccines].
    Peng F, Wei YQ.
    Ai Zheng; 2006 Aug; 25(8):1059-62. PubMed ID: 16965694
    [Abstract] [Full Text] [Related]

  • 2. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
    Anderson RJ, Schneider J.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B24-34. PubMed ID: 17698262
    [Abstract] [Full Text] [Related]

  • 3. Design of clinical trials for therapeutic cancer vaccines development.
    Mackiewicz J, Mackiewicz A.
    Eur J Pharmacol; 2009 Dec 25; 625(1-3):84-9. PubMed ID: 19835869
    [Abstract] [Full Text] [Related]

  • 4. TRICOM: enhanced vaccines as anticancer therapy.
    Levy B, Panicalli D, Marshall J.
    Expert Rev Vaccines; 2004 Aug 25; 3(4):397-402. PubMed ID: 15270644
    [Abstract] [Full Text] [Related]

  • 5. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, Nichol G, Cancer Vaccine Clinical Trial Working Group.
    J Immunother; 2007 Jan 25; 30(1):1-15. PubMed ID: 17198079
    [Abstract] [Full Text] [Related]

  • 6. DNA vaccines for cancer.
    Boyd D, Hung CF, Wu TC.
    IDrugs; 2003 Dec 25; 6(12):1155-64. PubMed ID: 14666426
    [Abstract] [Full Text] [Related]

  • 7. Recombinant viral vectors: cancer vaccines.
    Harrop R, John J, Carroll MW.
    Adv Drug Deliv Rev; 2006 Oct 01; 58(8):931-47. PubMed ID: 17030074
    [Abstract] [Full Text] [Related]

  • 8. Technology Insight: vaccine therapy for prostate cancer.
    Vieweg J, Dannull J.
    Nat Clin Pract Urol; 2005 Jan 01; 2(1):44-51. PubMed ID: 16474576
    [Abstract] [Full Text] [Related]

  • 9. Recent advances in heat shock protein-based cancer vaccines.
    Wang HH, Mao CY, Teng LS, Cao J.
    Hepatobiliary Pancreat Dis Int; 2006 Feb 01; 5(1):22-7. PubMed ID: 16481277
    [Abstract] [Full Text] [Related]

  • 10. Colorectal cancer vaccines: what we know and what we don't yet know.
    von Mehren M.
    Semin Oncol; 2005 Feb 01; 32(1):76-84. PubMed ID: 15726509
    [Abstract] [Full Text] [Related]

  • 11. Cancer vaccines: an update.
    Hipp JD, Hipp JA, Lyday BW, Minev BR.
    In Vivo; 2000 Feb 01; 14(5):571-85. PubMed ID: 11125541
    [Abstract] [Full Text] [Related]

  • 12. Vaccines for lymphomas: idiotype vaccines and beyond.
    Houot R, Levy R.
    Blood Rev; 2009 May 01; 23(3):137-42. PubMed ID: 18951668
    [Abstract] [Full Text] [Related]

  • 13. Cell based cancer vaccines: regulatory and commercial development.
    Copier J, Ward S, Dalgleish A.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B35-46. PubMed ID: 17916462
    [Abstract] [Full Text] [Related]

  • 14. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM.
    Immunol Rev; 2008 Apr 27; 222():316-27. PubMed ID: 18364011
    [Abstract] [Full Text] [Related]

  • 15. Current progress of DNA vaccine studies in humans.
    Lu S, Wang S, Grimes-Serrano JM.
    Expert Rev Vaccines; 2008 Mar 27; 7(2):175-91. PubMed ID: 18324888
    [Abstract] [Full Text] [Related]

  • 16. Recent advances in cancer vaccines: an overview.
    Itoh K, Yamada A, Mine T, Noguchi M.
    Jpn J Clin Oncol; 2009 Feb 27; 39(2):73-80. PubMed ID: 19015149
    [Abstract] [Full Text] [Related]

  • 17. Vaccination: role in metastatic melanoma.
    Pilla L, Valenti R, Marrari A, Patuzzo R, Santinami M, Parmiani G, Rivoltini L.
    Expert Rev Anticancer Ther; 2006 Aug 27; 6(8):1305-18. PubMed ID: 16925496
    [Abstract] [Full Text] [Related]

  • 18. Dendritic cell vaccines in melanoma: from promise to proof?
    Lesterhuis WJ, Aarntzen EH, De Vries IJ, Schuurhuis DH, Figdor CG, Adema GJ, Punt CJ.
    Crit Rev Oncol Hematol; 2008 May 27; 66(2):118-34. PubMed ID: 18262431
    [Abstract] [Full Text] [Related]

  • 19. Advances in specific immunotherapy for prostate cancer.
    Kiessling A, Füssel S, Wehner R, Bachmann M, Wirth MP, Rieber EP, Schmitz M.
    Eur Urol; 2008 Apr 27; 53(4):694-708. PubMed ID: 18061335
    [Abstract] [Full Text] [Related]

  • 20. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
    Berinstein NL.
    Ann N Y Acad Sci; 2009 Sep 27; 1174():107-17. PubMed ID: 19769743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.